These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1001 related articles for article (PubMed ID: 27046891)

  • 21. Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.
    Dukart J; Sambataro F; Bertolino A
    J Alzheimers Dis; 2016; 49(4):1143-59. PubMed ID: 26599054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
    Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
    J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latent diffusion model-based MRI superresolution enhances mild cognitive impairment prognostication and Alzheimer's disease classification.
    Yoon D; Myong Y; Kim YG; Sim Y; Cho M; Oh BM; Kim S
    Neuroimage; 2024 Aug; 296():120663. PubMed ID: 38843963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease.
    Giorgio J; Landau SM; Jagust WJ; Tino P; Kourtzi Z;
    Neuroimage Clin; 2020; 26():102199. PubMed ID: 32106025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
    Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
    Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.
    Chincarini A; Bosco P; Calvini P; Gemme G; Esposito M; Olivieri C; Rei L; Squarcia S; Rodriguez G; Bellotti R; Cerello P; De Mitri I; Retico A; Nobili F;
    Neuroimage; 2011 Sep; 58(2):469-80. PubMed ID: 21718788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's Disease Classification Based on Individual Hierarchical Networks Constructed With 3-D Texture Features.
    Liu J; Wang J; Hu B; Wu FX; Pan Y
    IEEE Trans Nanobioscience; 2017 Sep; 16(6):428-437. PubMed ID: 28541903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Locally linear embedding (LLE) for MRI based Alzheimer's disease classification.
    Liu X; Tosun D; Weiner MW; Schuff N;
    Neuroimage; 2013 Dec; 83():148-57. PubMed ID: 23792982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease.
    Schmitter D; Roche A; Maréchal B; Ribes D; Abdulkadir A; Bach-Cuadra M; Daducci A; Granziera C; Klöppel S; Maeder P; Meuli R; Krueger G;
    Neuroimage Clin; 2015; 7():7-17. PubMed ID: 25429357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An ensemble learning system for a 4-way classification of Alzheimer's disease and mild cognitive impairment.
    Yao D; Calhoun VD; Fu Z; Du Y; Sui J
    J Neurosci Methods; 2018 May; 302():75-81. PubMed ID: 29578038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data.
    Ye J; Farnum M; Yang E; Verbeeck R; Lobanov V; Raghavan N; Novak G; DiBernardo A; Narayan VA;
    BMC Neurol; 2012 Jun; 12():46. PubMed ID: 22731740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI.
    Misra C; Fan Y; Davatzikos C
    Neuroimage; 2009 Feb; 44(4):1415-22. PubMed ID: 19027862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of Alzheimer's disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning.
    Eskildsen SF; Coupé P; García-Lorenzo D; Fonov V; Pruessner JC; Collins DL;
    Neuroimage; 2013 Jan; 65():511-21. PubMed ID: 23036450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST.
    Mulder ER; de Jong RA; Knol DL; van Schijndel RA; Cover KS; Visser PJ; Barkhof F; Vrenken H;
    Neuroimage; 2014 May; 92():169-81. PubMed ID: 24521851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progression.
    Furney SJ; Kronenberg D; Simmons A; Güntert A; Dobson RJ; Proitsi P; Wahlund LO; Kloszewska I; Mecocci P; Soininen H; Tsolaki M; Vellas B; Spenger C; Lovestone S
    J Alzheimers Dis; 2011; 26 Suppl 3():395-405. PubMed ID: 21971479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ensembles of Deep Learning Architectures for the Early Diagnosis of the Alzheimer's Disease.
    Ortiz A; Munilla J; Górriz JM; Ramírez J
    Int J Neural Syst; 2016 Nov; 26(7):1650025. PubMed ID: 27478060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gaussian Discriminant Analysis for Optimal Delineation of Mild Cognitive Impairment in Alzheimer's Disease.
    Fang C; Li C; Cabrerizo M; Barreto A; Andrian J; Rishe N; Loewenstein D; Duara R; Adjouadi M
    Int J Neural Syst; 2018 Oct; 28(8):1850017. PubMed ID: 29793369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal Neuroimaging Hippocampal Markers for Diagnosing Alzheimer's Disease.
    Platero C; Lin L; Tobar MC
    Neuroinformatics; 2019 Jan; 17(1):43-61. PubMed ID: 29785624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predication of different stages of Alzheimer's disease using neighborhood component analysis and ensemble decision tree.
    Jin M; Deng W
    J Neurosci Methods; 2018 May; 302():35-41. PubMed ID: 29486213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
    Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L;
    J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.